July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Suppression of SPARC in human trabecular meshwork cells upregulates Plasminogen Activator Inhibitor-1
Author Affiliations & Notes
  • William MacDonald
    Ophthalmology and Visual Sciences, Case Western Reserve University, Shaker Heights, Ohio, United States
  • Min Hyung Kang
    Ophthalmology and Visual Sciences, Case Western Reserve University, Shaker Heights, Ohio, United States
  • Douglas J Rhee
    Ophthalmology and Visual Sciences, Case Western Reserve University, Shaker Heights, Ohio, United States
  • Footnotes
    Commercial Relationships   William MacDonald, None; Min Hyung Kang, None; Douglas Rhee, None
  • Footnotes
    Support  NIH RO1 EY019654
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 5141. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      William MacDonald, Min Hyung Kang, Douglas J Rhee; Suppression of SPARC in human trabecular meshwork cells upregulates Plasminogen Activator Inhibitor-1. Invest. Ophthalmol. Vis. Sci. 2019;60(9):5141.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Secreted Protein Acidic and Rich in Cysteine (SPARC) is an important regulator of the homeostasis of extracellular matrix (ECM) turnover in the trabecular meshwork (TM) of the eye.1 This is of particular interest due to the role that the TM plays in draining aqueous humor from the eye and regulating intraocular pressure (IOP), which is critical in the pathogenesis of glaucoma.2 Our purpose is to elucidate the molecular pathways that SPARC utilizes to affect the expression of certain ECM proteins. Plasminogen Activator Inhibitor-1 (PAI-1) is a protein involved in the turnover of ECM and regulated by SPARC. We hypothesize that suppressing SPARC will lead to the decrease of IOP in the expression of PAI-1.

Methods : Using primary TM cell culture (N=6) for in vitro experiments, we suppressed SPARC via SPARC suppressing lentivirus (lenti-shSPARC). TM endothelial cells were transduced by lenti-shSPARC at an MOI of 10. PAI-1 and SPARC proteins from cell lysates and conditioned media were analyzed by immunoblot. In addition, mRNA level of PAI-1 and SPARC from cell lysate were analyzed by quantitative polymerase chain reaction (qPCR).

Results : We observed that SPARC was suppressed (0.28 ± 0.12, p= 0.006, N=6) with shSPARC compared to shcontrol. Suppressed SPARC induced the elevation of PAI-1 at the protein (79.79 ± 66.36%, p = 0.036, N=6) and RNA (2.89 ± 1.14, p = 0.010, N=6) level compared to shcontrol.

Conclusions : SPARC suppression elevated the expression of PAI-1. PAI-1 may play a role for the IOP control in SPARC signaling pathway of human TM.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×